BONE AND RENAL SAFETY ARE IMPROVED IN CHRONIC HBV PATIENTS 1 YEAR AFTER SWITCHING TO TENOFOVIR ALAFENAMIDE (TAF) FROM TENOFOVIR DISOPROXIL FUMARATE (TDF)

---

Chan H. L. Y., Seto W. K., Buti M., Izumi N., Lim Y., Kao J., ...More

International Digestive Disease Forum (IDDF), Hong Kong, Hong Kong, 8 - 09 June 2019, vol.68, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 68
• Doi Number: 10.1136/gutjnl-2019-iddfabstracts.277
• City: Hong Kong
• Country: Hong Kong
• Istanbul University-Cerrahpasa Affiliated: No